← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

M

$ Value

$0

Shares

3,015

Price

$0

Filed

Nov 12

Insider

Name

Gray Nancy Ryan

Title

CIK

0001714949

Roles

Director

Transaction Details

Transaction Date

2025-11-07

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

This Option was previously reported as a Grant of 4,071 shares, which vested in full on June 06, 2020, at an exercise price of $113.5900 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer. | This Option was previously reported as a Grant of 3,452 shares, which vested in full on August 18, 2020, at an exercise price of $126.2600 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Filing Info

Accession No.

0002001011-25-000098

Form Type

4

Issuer CIK

0000886163

Gray Nancy Ryan's History

Date Ticker Type Value
2025-11-07 LGND M $235K
2025-11-07 LGND $731K
2025-11-07 LGND M $222K
2025-11-07 LGND $619K
2025-11-07 LGND M $0
2025-11-07 LGND M $0
2025-06-06 LGND A $0
2025-06-06 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01